| Kowal N, Aisner SC., Fitzhugh VA, Heller DS., Gynecologic Pathology, In:Anatomic
Pathology Board Review, Chapter 10. J. Leftowitch, ed. Elsevier Churchill Livingston,
New York, 3rd edition, in press.
|
| | Wakelee H, Dhalberg S, Keller S, Tester W, Aisner S, Rothman J, Patel J, Delaune R,
McDermott S, Shafqat A, Perez-Soler R, Chapman A, Kasbari S, Traynor A, Evans T, Horn
L, Graziano S, Gandara D, Adjei A, Butts C, Leighl N, Ramalingam S, Schiller J: E
1505; Adjuvant Chemotherapy +/- Bevacizumab for early stage NSCLC: Updated
chemotherapy Subset Analysis. IASLC, September, (accepted for presentation September
2019)
|
| | Portal DE, Weiss RE, Wojtowicz M, Mansour A, Monken C, Mehnert JM, Aisner J, Kane M,
nishioka J, Aisner S, Peters S, Stein MN, Kim IY, Mayer TM, Shih W, Gulley J,
Streicher H, Singer EA, Lattime EC.: Phase 1 Neoadjuvant Study of Intravescial
Recombinant Fowlpox-GM-CSF(rF-GM-CSF) or Fowlpox-Tricom (rF-TRICOM) in Patients with
Bladder Cancer. Cancer Gene Therapy, 2019 Jun 20. PMID 31222182
|
| | Wakelee HA, Dahlberg SE, Keller SM, Tester WJ, Gandara DR, Graziano SL, Adjei A,
Leighl NB, Aisner SC, Rothman, JM, Patel JD, Sborov MD, McDermott SR, Perez-Soler
R, Traynor A, Butts C, Evans T, Shafqat A, Chapman AE, Kasbari SS, Horn H,
Ramalingam SS, Schiller J.: Adjuvant Chemotherapy with or without bevacizumab in
patients with resected non-small cell lung cancer (NSCLC): Results of E 1505: An open
label multicenter randomised phase III trial. Lancet oncology, 2017, Dec; 18(12),
1610-1623. PMID 29129443 |
| | Belinsky SA, Leng S, Wu G, Thomas CL, Picchi MA, Lee SJ, Aisner S, Ramalingam S,
Khuri FR, Karp DD.: Gene Methylation Biomarkers in Sputum and Plasma as Predictors
for Lung Cancer Recurrence. 2017 Cancer Prev Rev (Phila). Nov; 10(11): 635-640.
PMID: 28904059 |
| | Thunnissen E, Borczuk AC, Flieder DB, Witte B, Beasley MB, Chung JH, Dacic S,
Lantuejoul S, Russell PA, den Bakker M, Botling J, Brambilla E, de Cuba E, Geisinger
KR, Hiroshima K, Marchevsky AM, Minami Y, Moreira A, Nicholson AG, Yoshida A,
Tsao MS, Warth A, Duhig E, Chen G, M, Matsuno Y, Travis WD, Butnor K, Cooper W,
Mino-Kenudson M, Motoi N, Poleri C, Pelosi G, Kerr K, Aisner SC, Ishikawa Y,
Buettner RH, Keino N, Yatabe Y, Noguchi M.: The Use of Immunohistochemistry
Improved the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An
International Reproducibility Study in a Demanding set of Cases. J. Thorac Oncol,
Feb.
2017; Vol 12, no 2, pp 334-346. PMID: 27998793 |
| | Fitzhugh VA, Wenokor C, Beebe KS, Aisner SC.: Leiomyoma of deep soft tissue
mimicking calcific myonecrosis. Radiology Case Reports. 2016:17; 11 (4): 430-433.
PMID: 27920874 |
| | Neal JW, Dahlberg SE, Wakelee HA, Aisner SC, Bowden M, Huang Y, Carbone DP,
Gerstner GJ, Lerner RE, Rubin JL, Owonikoko TK, Stella PJ, Steen PD, Khalid AA,
Ramalingam SS.: Erolotinib, cabozatinib, or erlotinib plus cabozantinib as a second
or
third line treatment of patients with EGFR wild-type advanced non-small cell lung
cancer (ECOG-ACRIN 1512): a phase 2 randomised control trial. Lancet Oncology 2016
Dec; 17 (12): 1661-1671. PMID: 27825638 |
| | Nicholson AG, Geisinger K, Aisner SC, Al-Dayel F, Bubendorf L, Chung J-H, Kerr KM,
Meyerson M, Noguchi M, Olszewski W, Rekhtman N, Riely G, Scagliotti G, Travis WD.
:Terminology and Criteria in non-resection specimens. In; Pathology and Genetics:
Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization
Classification of Tumorous 4th ed. Eds. TravisWD, Brambilla, IARC Press 2015, pp 16-
21, Lyon France. |
| | Travis WD, Yatabe Y, Brambilla E, Ishikawa Y, Nicholson AG, Aisner SC, Austin
JHM, Meyerson M, Nakatani Y, Powell CA, Rami-Porta R, Rekhtman N, Reily G, Rossi
G, Russell P, Samet J, Scagliotti G, Thunnissen E, Tsuta, K, van Schil P, Warth A,
Wistuba II, Yankelevitz D.:Variants of Adenocarcinoma. In; Pathology and Genetics:
Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization
Classification of Tumorous 4th ed. Eds. TravisWD, Brambilla, IARC Press 2015, pp 38-
43, Lyon France. |
|
